In the current study, we found that knockdown of PRDX2 downregulated the expression of Bcl-2, while upregulated the expression of Bax, cleaved caspase 3 and cleaved caspase 9 in NSCLC cells. The gene discussed is CASP3; the disease is non-small cell lung carcinoma.